马尔尼菲青霉菌的分离鉴定与耐药性分析
发布时间:2018-12-11 07:33
【摘要】:目的分析马尔尼菲青霉菌(PMA)在无基础疾病低龄患儿的感染状况及耐药性,为马尔尼菲青霉菌病(PSM)患儿选择及时、有效的抗真菌治疗提供依据。方法收集2006年1月-2014年12月23例马尔尼菲青霉病患儿血液和骨髓标本中分离的PMA,从细菌学检验、骨髓像染色检查、组织病理学常规染色和特殊染色检查鉴定PMA,并且采用Rosoo纸片扩散法进行马尔尼菲青霉菌药物敏感性试验。结果 BACT/ALERT 3D120全自动血液培养仪提示有菌生长;糖同化试验均阳性;组织病理学常规染色显示为肉芽肿病变,中心坏死,并见典型细胞为腊肠形孢子,长形、、粗细均匀、两头钝圆、中央有一横隔;23株马尔尼菲青霉菌对5种抗真菌药物抗菌活性均较好,两性霉素B、伏立康唑、氟胞嘧啶、伊曲康唑的耐药率分别为13.0%、8.7%、4.3%、4.3%。结论马尔尼菲青霉菌已严重危害免疫力低下的低龄儿童,需严防漏检而贻误治疗时机,尤其重视降低基层医院的马尔尼菲青霉菌病的误诊率,因氟康唑敏感性高、能透过血脑屏障、不良反应小、治疗费用较低,所以在马尔尼菲青霉病患儿治疗上推荐首选药物为氟康唑。
[Abstract]:Objective to analyze the infection status and drug resistance of Penicillium marneffei (PMA) in young children without basic diseases, and to provide evidence for the choice of timely and effective antifungal therapy in children with penicilliosis marneffei (PSM). Methods PMA, isolated from blood and bone marrow samples of 23 children with penicilliosis marneffei were collected from January 2006 to December 2014 to identify PMA, from bacteriological examination, bone marrow image staining, histopathological routine staining and special staining. The drug sensitivity of Penicillium marneffei was tested by Rosoo disk diffusion method. Results BACT/ALERT 3D120 automatic blood culture instrument indicated the growth of bacteria, and the glucose assimilation test was positive. Histopathological staining showed granulomatous lesions with central necrosis. Typical cells were sausage spores, long, thin and uniform, with obtuse circles at both ends and a horizontal septum in the center. 23 strains of Penicillium marneffei had better antimicrobial activity against 5 kinds of antifungal drugs. The resistance rates of amphotericin B, voliconazole, flucytosine and itraconazole were 13.0 and 8.7 respectively. Conclusion Penicillium marneffei has been seriously harmful to the young children with low immunity. It is necessary to prevent the missed examination and delay the treatment opportunity, especially to reduce the misdiagnosis rate of penicilliosis marneffei in the primary hospital because of the high sensitivity of fluconazole. Can penetrate the blood-brain barrier, the adverse reaction is small, the treatment cost is low, therefore in the Marneffei penicillium disease child treatment recommended the first choice drug is fluconazole.
【作者单位】: 赣南医学院第一附属医院检验科;赣南医学院第三附属医院检验科;赣南医学院第一附属医院血液实验室;赣南医学院第一附属医院病理科;
【基金】:江西省自然科学基金项目(2012ZBAB205007) 江西省教育厅青年科学基金项目(GJJ10229)
【分类号】:R446;R725.1
本文编号:2372149
[Abstract]:Objective to analyze the infection status and drug resistance of Penicillium marneffei (PMA) in young children without basic diseases, and to provide evidence for the choice of timely and effective antifungal therapy in children with penicilliosis marneffei (PSM). Methods PMA, isolated from blood and bone marrow samples of 23 children with penicilliosis marneffei were collected from January 2006 to December 2014 to identify PMA, from bacteriological examination, bone marrow image staining, histopathological routine staining and special staining. The drug sensitivity of Penicillium marneffei was tested by Rosoo disk diffusion method. Results BACT/ALERT 3D120 automatic blood culture instrument indicated the growth of bacteria, and the glucose assimilation test was positive. Histopathological staining showed granulomatous lesions with central necrosis. Typical cells were sausage spores, long, thin and uniform, with obtuse circles at both ends and a horizontal septum in the center. 23 strains of Penicillium marneffei had better antimicrobial activity against 5 kinds of antifungal drugs. The resistance rates of amphotericin B, voliconazole, flucytosine and itraconazole were 13.0 and 8.7 respectively. Conclusion Penicillium marneffei has been seriously harmful to the young children with low immunity. It is necessary to prevent the missed examination and delay the treatment opportunity, especially to reduce the misdiagnosis rate of penicilliosis marneffei in the primary hospital because of the high sensitivity of fluconazole. Can penetrate the blood-brain barrier, the adverse reaction is small, the treatment cost is low, therefore in the Marneffei penicillium disease child treatment recommended the first choice drug is fluconazole.
【作者单位】: 赣南医学院第一附属医院检验科;赣南医学院第三附属医院检验科;赣南医学院第一附属医院血液实验室;赣南医学院第一附属医院病理科;
【基金】:江西省自然科学基金项目(2012ZBAB205007) 江西省教育厅青年科学基金项目(GJJ10229)
【分类号】:R446;R725.1
【相似文献】
相关期刊论文 前10条
1 杨宁;李妍;王晗;李沛然;苑文雯;郭桐生;;骨髓涂片镜检初步诊断马尔尼菲青霉菌1例及文献复习[J];中国实验诊断学;2014年08期
2 廖晚珍,胡雪飞,胡意,孙爱娣;我省首次发现马尔尼菲青霉菌[J];江西医学检验;2001年03期
3 廖晚珍;马尔尼菲青霉菌与马尔昆菲青菌病[J];江西医学检验;2001年05期
4 谢宁;;马尔尼菲青霉菌的分离鉴定和在临床标本中的分布[J];检验医学与临床;2011年14期
5 零培长;;43例马尔尼菲青霉菌的培养体会[J];当代医药论丛;2014年01期
6 王朝宏;郝冀洪;朱芸;刘青芹;;马尔尼菲青霉菌细胞化学染色研究[J];临床荟萃;2006年14期
7 郭健莲;江先海;谢志雄;李强;;艾滋病感染马尔尼菲青霉菌一例[J];实验与检验医学;2011年02期
8 李晓红;赖敏玲;;1例艾滋病合并马尔尼菲青霉菌败血症的护理[J];中国医疗前沿;2009年05期
9 刘存旭;唐秀文;廖光付;李月水;;4种方法对马尔尼菲青霉菌染色效果比较[J];广西医科大学学报;2010年01期
10 梁伶,邱实,韦高,程鹂;酵母相马尔尼菲青霉菌体外抗真菌药敏试验研究[J];中国皮肤性病学杂志;2001年04期
相关会议论文 前1条
1 李宏军;张玉忠;吴昊;;艾滋病合并马尔尼菲青霉菌肺炎的CT群聚空洞特征表现[A];中华医学会第四次全国艾滋病、病毒性丙型肝炎暨全国热带病学术会议论文汇编[C];2009年
,本文编号:2372149
本文链接:https://www.wllwen.com/huliyixuelunwen/2372149.html
最近更新
教材专著